Adult Congenital Heart Disease Clinic
Thanks to advances in both surgical treatments and medications, more and more children born with heart defects are surviving to adulthood. In addition, minor congenital heart defects that don't cause symptoms in children may be diagnosed when you're an adult. An estimated 20,000 people with congenital heart disease reach adulthood every year in the United States.
While most adults with congenital heart disease lead full and active lives, you may experience lifelong problems related to your heart defect, including abnormal heart rhythms, heart failure or deterioration of heart repair done in childhood.
The UCSF Adult Congenital Heart Disease Clinic offers comprehensive care that includes early detection of problems, treatment to prevent complications and surgical repair of defects. For adults with congenital heart disease, at least one visit at a center focused on the disease is recommended. For people with mild levels of disease, regular monitoring of the defect and heart function may be the only treatment necessary. For others, treatment ranges from medication to surgery, including heart and lung transplants.
At our clinic, experts who specialize in treating adults with congenital heart disease work with heart surgeons, pediatric heart specialists, diagnostic specialists and other health professionals to provide quality care for even the rarest defects.
Our mission is to enable our patients to live as active a life as possible.
If you're pregnant or considering pregnancy, our Cardio-Obstetrics team provides specialized prenatal and preconception care for women with heart disease. Learn more about our Pregnancy and Cardiac Treatment (PACT) Program.
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary...
Defined as a non-hierarchical composite of: RVOT reintervention, Moderate or greater total pulmonary regurgitation (PR) via Transthoracic Echocardiography (TTE), Mean RVOT gradient > 40 mmHg via TTE
AMPLATZER PFO Occluder Post Approval Study
5 year rate of recurrent ischemic stroke
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Mitral Valve Syste...
Survival free of heart failure hospitalization at 12 months post index procedure
BioVentrix Revivent TC™ System Clinical Study
Composite primary safety endpoint of all cause death, placement of a mechanical support device intra or post-op (IABP, VAD, ECMO or catheter based), emergent cardiac surgery including reoperation for bleeding or tamponade, prolong...
Plan your visit
What to Bring
- Photo I.D.
- Health insurance card
- Insurance authorization, if required
- Doctor's referral, if required
- Recent test results related to your condition
- List of your medications, including dosages, plus any you're allergic to
- List of questions you may have
- Device or paper for taking notes